Elaine D. Sun

2020

In 2020, Elaine D. Sun earned a total compensation of $3.4M as Senior Vice President Chief Financial Officer at Halozyme Therapeutics.

Compensation breakdown

Bonus$150,000
Non-Equity Incentive Plan$180,352
Option Awards$1,000,008
Salary$395,833
Stock Awards$1,500,269
Other$133,399
Total$3,359,861

Sun received $1.5M in stock awards, accounting for 45% of the total pay in 2020.

Sun also received $150K in bonus, $180.4K in non-equity incentive plan, $1M in option awards, $395.8K in salary and $133.4K in other compensation.

Rankings

In 2020, Elaine D. Sun's compensation ranked 3,459th out of 13,090 executives tracked by ExecPay. In other words, Sun earned more than 73.6% of executives.

ClassificationRankingPercentile
All
3,459
out of 13,090
74th
Division
Manufacturing
1,348
out of 5,618
76th
Major group
Chemicals And Allied Products
508
out of 2,251
77th
Industry group
Drugs
441
out of 1,951
77th
Industry
Biological Products, Except Diagnostic Substances
108
out of 411
74th

Pay ratio

Elaine D. Sun's Pay$3,359,861
Median Employee's Pay$223,441
Pay Ratio

15

to 1

In 2020, the annual total compensation of Elaine D. Sun was $3,359,861.

The annual total compensation of the median employee at Halozyme Therapeutics was $223,441.

The ratio of Elaine D. Sun's pay to the pay of median employee was therefore 15 to one.

Source: SEC filing on March 26, 2021.

Sun's colleagues

We found four more compensation records of executives who worked with Elaine D. Sun at Halozyme Therapeutics in 2020.

2020

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2020

Michael LaBarre

Halozyme Therapeutics

Senior Vice President, Chief Technical Officer

2020

Masaru Matsuda

Halozyme Therapeutics

General Counsel

2020

Laurie Stelzer

Halozyme Therapeutics

Chief Financial Officer

News

You may also like